Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

Gynecologic Oncology
Nicole UrbanGarnet L Anderson

Abstract

We developed and validated a hybrid risk classifier combining serum markers and epidemiologic risk factors to identify post-menopausal women at elevated risk for invasive fallopian tube, primary peritoneal, and ovarian epithelial carcinoma. To select epidemiologic risk factors for use in the classifier, Cox proportional hazards analyses were conducted using 74,786 Women's Health Initiative (WHI) Observational Study (OS) participants. To construct a combination classifier, 210 WHI OS cases and 536 matched controls with serum marker measurements were analyzed; validation employed 143 cases and 725 matched controls from the WHI Clinical Trial (CT) with similar data. Analyses identified a combination risk classifier composed of two elevated-risk groups: 1) women with CA125 or HE4 exceeding a 98% specificity threshold; and 2) women with intact fallopian tubes, prior use of menopausal hormone therapy for at least two years, and either a first degree relative with breast or ovarian cancer or a personal history of breast cancer. In the WHI OS population, it classified 13% of women as elevated risk, identifying 30% of ovarian cancers diagnosed up to 7.8years post-enrollment (Hazard Ratio [HR]=2.6, p<0.001). In the WHI CT validation popu...Continue Reading

References

Nov 1, 1992·Gynecologic Oncology·J F LeakeJ D Woodruff
Sep 22, 2005·Journal of the National Cancer Institute·Noah D KauffKenneth Offit
Apr 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Brenda B J HermsenRené H M Verheijen
Jul 13, 2007·Current Opinion in Obstetrics & Gynecology·William H ParkerJonathan S Berek
Jan 15, 2009·Journal of the National Cancer Institute·Timothy R RebbeckSusan M Domchek
Feb 25, 2009·Gynecologic Oncology·Ann K FolkinsChristopher P Crum
Apr 23, 2009·Molecular Oncology·Susan J Ramus, Simon A Gayther
Dec 1, 2009·Gynecologic Oncology·M Robyn AndersenNicole Urban
Apr 8, 2011·Obstetrics and Gynecology·Allison F VitonisDaniel W Cramer
Jul 22, 2011·Obstetrics and Gynecology·Clara PlusquinSerge Rozenberg
Aug 19, 2011·Human Reproduction·J DietlS F M Häusler
Sep 16, 2011·Journal of the National Cancer Institute·Nicole UrbanCharles W Drescher
Apr 21, 2012·American Journal of Epidemiology·Lina Steinrud MørchOjvind Lidegaard
Sep 11, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Nicole UrbanCharles W Drescher
Dec 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam N RosenthalIan J Jacobs
Jan 4, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sara J SchonfeldWilliam F Anderson
Jan 15, 2013·Cancer Causes & Control : CCC·Cyllene R MorrisKurt Snipes
Mar 26, 2013·International Journal of Cancer. Journal International Du Cancer·Virpi Koskela-NiskaTadeusz Dyba
Jan 15, 2014·American Journal of Obstetrics and Gynecology·Jessica N McAlpineUNKNOWN Ovarian Cancer Research Program of British Columbia
Jan 28, 2015·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Celeste Leigh PearcePaul D P Pharoah

❮ Previous
Next ❯

Citations

Jul 25, 2017·American Journal of Obstetrics and Gynecology·Jacques S Abramowicz, Dirk Timmerman
Sep 29, 2017·Clinical Obstetrics and Gynecology·Janice S Kwon
May 14, 2020·Journal of Toxicology and Environmental Health. Part B, Critical Reviews·Julie E GoodmanCharlotte M Marsh
Jul 16, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Steven J Skates
Apr 10, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathryn L TerryRudolf Kaaks
Aug 14, 2021·Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society·Yan SunLing Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

The New England Journal of Medicine
Rowan T ChlebowskiWomen's Health Initiative Investigators
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Beth Y KarlanNicole Urban
© 2021 Meta ULC. All rights reserved